XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Formation and Business of the Company - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
May 07, 2019
Jun. 01, 2016
Jul. 31, 2016
Mar. 31, 2019
Grant [Line Items]        
Revenue from product development award       $ 1,699,000
Cancer Prevention & Research Institute of Texas [Member]        
Grant [Line Items]        
Revenue from product development award     $ 20,000,000  
Initial grant termination date   May 31, 2019    
Percentage of cash required to raise in matching funds   50.00%    
Cash required to raise in matching funds   $ 10,000,000    
Term of project during which cash required to raise in matching funds   3 years    
Cash required in matching funds raised   $ 10,000,000    
Percentage of grant award proceeds required to pay   400.00%    
Cancer Prevention & Research Institute of Texas [Member] | Maximum [Member]        
Grant [Line Items]        
Percentage of grant award proceeds required to pay thereafter until government exclusivity maintained   1.00%    
Cancer Prevention & Research Institute of Texas [Member] | Subsequent Event [Member]        
Grant [Line Items]        
Extension of grant termination date Nov. 30, 2019      
Stanford University [Member] | Maximum [Member]        
Grant [Line Items]        
Milestone payments upon achievement of clinical and regulatory milestones       $ 1,000,000